Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 2000, p. 3310-3316, Vol. 44, No. 12
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Salivary Histatin 5 and Human Neutrophil Defensin 1 Kill Candida albicans via Shared Pathways
Mira
Edgerton,1,2,*
Svetlana
E.
Koshlukova,1
Marcelo W. B.
Araujo,1
Rashmi C.
Patel,1
Jin
Dong,1 and
Jeremy A.
Bruenn3
Departments of Oral
Biology,1 Restorative
Dentistry,2 and Biological
Sciences,3 State University of New York at
Buffalo, Buffalo, New York 14214
Received 24 May 2000/Returned for modification 26 July
2000/Accepted 5 September 2000
Salivary histatins are a family of basic histidine-rich proteins in
which therapeutic potential as drugs against oral candidiasis is
apparent, considering their potent in vitro antifungal activity and
lack of toxicity to humans. Histatin 5 (Hst 5) kills the fungal pathogen Candida albicans via a mechanism that involves
binding to specific sites on the yeast cell membrane and subsequent
release of cellular ATP in the absence of cytolysis. We explored the
killing pathway activated by Hst 5 and compared it to those activated by other antifungal agents. The candidacidal activity of human neutrophil defensin 1 (HNP-1) shared very similar features to Hst 5 cytotoxic action with respect to active concentrations and magnitude of
induction of nonlytic ATP efflux, depletion of intracellular ATP pools,
and inhibitor profile. Hst 5 and HNP-1 are basic proteins of about 3 kDa; however, they have unique primary sequences and solution
structures that cannot explain how these two molecules act so similarly
on C. albicans to induce cell death. Our finding that HNP-1
prevented Hst 5 binding to the candidal Hst 5 binding protein suggests
that the basis for the overlapping actions of these two naturally
occurring antimicrobial proteins may involve interactions with shared
yeast components.
*
Corresponding author. Mailing address: 310 Foster Hall,
SUNY at Buffalo Main Street Campus, 3435 Main St., Buffalo, NY 14214. Phone: (716) 829-3067. Fax: (716) 829-3942. E-mail:
edgerto{at}buffalo.edu.
Antimicrobial Agents and Chemotherapy, December 2000, p. 3310-3316, Vol. 44, No. 12
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., Filler, S. G., Masso-Welch, P., Edgerton, M., Gaffen, S. L.
(2009). Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. JEM
206: 299-311
[Abstract]
[Full Text]
-
Chaffin, W. L.
(2008). Candida albicans Cell Wall Proteins. Microbiol. Mol. Biol. Rev.
72: 495-544
[Abstract]
[Full Text]
-
Beiter, K., Wartha, F., Hurwitz, R., Normark, S., Zychlinsky, A., Henriques-Normark, B.
(2008). The Capsule Sensitizes Streptococcus pneumoniae to {alpha}-Defensins Human Neutrophil Proteins 1 to 3. Infect. Immun.
76: 3710-3716
[Abstract]
[Full Text]
-
Gank, K. D., Yeaman, M. R., Kojima, S., Yount, N. Y., Park, H., Edwards, J. E. Jr., Filler, S. G., Fu, Y.
(2008). SSD1 Is Integral to Host Defense Peptide Resistance in Candida albicans. Eukaryot Cell
7: 1318-1327
[Abstract]
[Full Text]
-
Wei, G.-X., Campagna, A. N., Bobek, L. A.
(2006). Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother
57: 1100-1109
[Abstract]
[Full Text]
-
Vylkova, S., Li, X. S., Berner, J. C., Edgerton, M.
(2006). Distinct Antifungal Mechanisms: {beta}-Defensins Require Candida albicans Ssa1 Protein, while Trk1p Mediates Activity of Cysteine-Free Cationic Peptides. Antimicrob. Agents Chemother.
50: 324-331
[Abstract]
[Full Text]
-
Feng, Z., Jiang, B., Chandra, J., Ghannoum, M., Nelson, S., Weinberg, A.
(2005). Human Beta-defensins: Differential Activity against Candidal Species and Regulation by Candida albicans. JDR
84: 445-450
[Abstract]
[Full Text]
-
Okamoto, T., Tanida, T., Wei, B., Ueta, E., Yamamoto, T., Osaki, T.
(2004). Regulation of Fungal Infection by a Combination of Amphotericin B and Peptide 2, a Lactoferrin Peptide That Activates Neutrophils. CVI
11: 1111-1119
[Abstract]
[Full Text]
-
Bowdish, D. M. E., Davidson, D. J., Speert, D. P., Hancock, R. E. W.
(2004). The Human Cationic Peptide LL-37 Induces Activation of the Extracellular Signal-Regulated Kinase and p38 Kinase Pathways in Primary Human Monocytes. J. Immunol.
172: 3758-3765
[Abstract]
[Full Text]
-
Joly, S., Maze, C., McCray, P. B. Jr., Guthmiller, J. M.
(2004). Human {beta}-Defensins 2 and 3 Demonstrate Strain-Selective Activity against Oral Microorganisms. J. Clin. Microbiol.
42: 1024-1029
[Abstract]
[Full Text]
-
Li, X. S., Reddy, M. S., Baev, D., Edgerton, M.
(2003). Candida albicans Ssa1/2p Is the Cell Envelope Binding Protein for Human Salivary Histatin 5. J. Biol. Chem.
278: 28553-28561
[Abstract]
[Full Text]
-
Bobek, L. A., Situ, H.
(2003). MUC7 20-Mer: Investigation of Antimicrobial Activity, Secondary Structure, and Possible Mechanism of Antifungal Action. Antimicrob. Agents Chemother.
47: 643-652
[Abstract]
[Full Text]
-
Lupetti, A., Paulusma-Annema, A., Senesi, S., Campa, M., van Dissel, J. T., Nibbering, P. H.
(2002). Internal Thiols and Reactive Oxygen Species in Candidacidal Activity Exerted by an N-Terminal Peptide of Human Lactoferrin. Antimicrob. Agents Chemother.
46: 1634-1639
[Abstract]
[Full Text]
-
Edgerton, M., Koshlukova, S.E.
(2000). Salivary Histatin 5 and its Similarities to the Other Antimicrobial Proteins in Human Saliva. ADR
14: 16-21
[Abstract]
-
Helmerhorst, E. J., Troxler, R. F., Oppenheim, F. G.
(2001). The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc. Natl. Acad. Sci. USA
98: 14637-14642
[Abstract]
[Full Text]